A. Jurj

发表

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells

I. Berindan‐Neagoe, C. Braicu, E. Bodoki, 2018, Cancer management and research.

C , O ‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity

I. Berindan‐Neagoe, C. Silvestru, Paul Chiroi, 2022, Applied Organometallic Chemistry.

A narrative review of central nervous system involvement in acute leukemias

Alina-Andreea Zimta, S. Pașca, B. Petrushev, 2021, Annals of translational medicine.

The new era of nanotechnology, an alternative to change cancer treatment

Ioana Berindan-Neagoe, Cornelia Braicu, Ciprian Tomuleasa, 2017, Drug design, development and therapy.

Walnut (Juglans regia L.) Septum: Assessment of Bioactive Molecules and In Vitro Biological Effects

I. Berindan‐Neagoe, D. Vodnar, L. Vlase, 2020, Molecules.

Phytochemical Analysis and In Vitro Effects of Allium fistulosum L. and Allium sativum L. Extracts on Human Normal and Tumor Cell Lines: A Comparative Study

A. Moț, A. Farcaș, C. Moldovan, 2021, Molecules.

The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells

I. Berindan‐Neagoe, A. Moț, C. Moldovan, 2020, Molecules.

Protein dysregulation in graft versus host disease

I. Berindan‐Neagoe, A. Irimie, B. Petrushev, 2017, Oncotarget.

Next generation sequencing applications for breast cancer research

D. Dumitrascu, N. Dragoș, L. Pop, 2015, Clujul medical.

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia

H. Einsele, I. Berindan‐Neagoe, Alina-Andreea Zimta, 2019, Frontiers in Immunology.

Theranostic Nanoparticles and Their Spectrum in Cancer

I. Berindan‐Neagoe, C. Moldovan, Anca Onaciu, 2019, Engineered Nanomaterials - Health and Safety.

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

I. Berindan‐Neagoe, C. Braicu, C. Ionescu, 2022, Journal of Experimental & Clinical Cancer Research.

Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis

J. Bergthórsson, Alina-Andreea Zimta, S. Pașca, 2020, Journal of cellular and molecular medicine.

Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma

O. Almășan, C. Dinu, H. Rotaru, 2022, Medicina.

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy

T. Ciuleanu, D. Cenariu, S. Pașca, 2021, Journal of cellular and molecular medicine.

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?

Alina-Andreea Zimta, S. Pașca, D. Coriu, 2020, Frontiers in Oncology.

SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome

C. Blag, Alina-Andreea Zimta, S. Pașca, 2021, Frontiers in Bioengineering and Biotechnology.

Focus on organoids: cooperation and interconnection with extracellular vesicles - is this the future of in vitro modeling?

I. Berindan‐Neagoe, S. Korban, S. Pașca, 2021, Seminars in cancer biology.

A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells

V. Lazar, I. Berindan‐Neagoe, A. Irimie, 2020, Cancers.

Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology

I. Berindan‐Neagoe, O. Bălăcescu, C. Braicu, 2016, BMC Genomics.

Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer

I. Berindan‐Neagoe, S. Korban, O. Slabý, 2020, International journal of molecular sciences.

Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer

I. Berindan‐Neagoe, J. Sabourin, C. Braicu, 2022, International journal of molecular sciences.

The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”

Ioana Berindan-Neagoe, Diana Gulei, Lavinia L. Pruteanu, 2019, International journal of molecular sciences.

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2018, Critical reviews in clinical laboratory sciences.

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2019, Journal of experimental & clinical cancer research : CR.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient

A. Paradiso, I. Berindan‐Neagoe, A. Irimie, 2018, Journal of experimental & clinical cancer research : CR.

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples

I. Berindan‐Neagoe, A. Irimie, C. Braicu, 2017, OncoTargets and therapy.

Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death

I. Berindan‐Neagoe, C. Braicu, V. Pileczki, 2018, Experimental and therapeutic medicine.

Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2020, Cancers.

Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer

I. Berindan‐Neagoe, E. Fuentes-Mattei, C. Braicu, 2017, Experimental and therapeutic medicine.

MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.

C. Blag, Alina-Andreea Zimta, S. Pașca, 2020, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression

I. Berindan‐Neagoe, Lorand Magdo, S. Pașca, 2018, Cell Death & Disease.

Isolation and Characterization of a Fetal-Maternal Microchimeric Stem Cell Population in Maternal Hair Follicles Long after Parturition

O. Sorițău, C. Moldovan, C. Cismaru, 2019, Stem Cell Reviews and Reports.

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors

I. Berindan‐Neagoe, C. Braicu, V. Pileczki, 2016, OncoTargets and therapy.

Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic

I. Berindan‐Neagoe, S. Korban, A. Irimie, 2020, Cancers.

Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment.

S. Pașca, Ancuta Jurj, C. Selicean, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Basic knowledge on BCR-ABL1-positive extracellular vesicles.

I. Berindan‐Neagoe, S. Pașca, C. Tomuleasa, 2020, Biomarkers in medicine.

miR‐181a/b therapy in lung cancer: reality or myth?

G. Calin, I. Berindan‐Neagoe, Erik Knutsen, 2019, Molecular oncology.

Human Chorionic Gonadotropin Improves the Proliferation and Regenerative Potential of Bone Marrow Adherent Stem Cells and the Immune Tolerance of Fetal Microchimeric Stem Cells In Vitro

C. Braicu, O. Sorițău, C. Moldovan, 2020, Stem Cell Reviews and Reports.

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

I. Berindan‐Neagoe, Alina-Andreea Zimta, A. Irimie, 2020, Journal of experimental & clinical cancer research : CR.

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2018, Front. Immunol..

Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene

I. Berindan‐Neagoe, Alina-Andreea Zimta, D. Cenariu, 2021, Pharmaceutics.

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients

Alina-Andreea Zimta, S. Pașca, B. Petrushev, 2020, Diagnostics.

B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?

Alina-Andreea Zimta, S. Pașca, B. Petrushev, 2020, Journal of clinical medicine.

The Effect of Different Anesthetic Techniques on Proliferation, Apoptosis, and Gene Expression in Colon Cancer Cells: A Pilot In Vitro Study

C. Tomuleasa, A. Țigu, D. Ionescu, 2023, Current issues in molecular biology.

How to Diagnose and Treat a Cancer of Unknown Primary Site.

I. Berindan‐Neagoe, Z. Fekete, C. Tomuleasa, 2017, Journal of gastrointestinal and liver diseases : JGLD.

Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells

I. Berindan‐Neagoe, O. Sorițău, R. Cȃmpian, 2020, Medicina.

Angioimmunoblastic T cell Lymphoma Microenvironment

D. Matei, S. Pașca, A. Jurj, 2020 .

Progress in Research on the Role of Flavonoids in Lung Cancer

I. Berindan‐Neagoe, C. Braicu, Ancuta Jurj, 2019, International journal of molecular sciences.

New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin

I. Berindan‐Neagoe, S. Korban, C. Braicu, 2020, Molecular and Cellular Biochemistry.

Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health

I. Berindan‐Neagoe, C. Braicu, Diana Gulei, 2016, BMC Genomics.

The Potential Equivalents of TET2 Mutations

S. Pașca, C. Tomuleasa, M. Zdrenghea, 2021, Cancers.

Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer

I. Berindan‐Neagoe, Alina-Andreea Zimta, C. Braicu, 2017, International journal of nanomedicine.

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

I. Berindan‐Neagoe, Alina-Andreea Zimta, A. Irimie, 2020, Journal of Experimental & Clinical Cancer Research.

Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients

L. Barbu-Tudoran, O. Bălăcescu, V. Pileczki, 2022, International journal of molecular sciences.

Salivary exosomal microRNAs as biomarkers for head and neck cancer detection—a literature review

H. Rotaru, C. Faur, M. Chirilă, 2021, Maxillofacial plastic and reconstructive surgery.

A miRNAs profile evolution of triple negative breast cancer cells in the presence of a possible adjuvant therapy and senescence inducer.

I. Berindan‐Neagoe, C. Braicu, V. Pileczki, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Isolation and Characterization of a Fetal-Maternal Microchimeric Stem Cell Population in Maternal Hair Follicles Long after Parturition

O. Sorițău, C. Moldovan, Ancuta Jurj, 2019, Stem Cell Reviews and Reports.

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression

I. Berindan‐Neagoe, Lorand Magdo, S. Pașca, 2018, Cell Death & Disease.

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

S. Aștilean, A. Buzoianu, I. Berindan‐Neagoe, 2016, International journal of nanomedicine.

Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer

I. Berindan‐Neagoe, C. Braicu, L. Pop, 2023, International journal of molecular sciences.

At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets.

G. Calin, K. Litchfield, A. Jurj, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathy.

S. Pașca, B. Petrushev, N. Leopold, 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2019, Journal of Experimental & Clinical Cancer Research.

CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia.

Juergen Popp, Ioana Berindan-Neagoe, Sanda Boca, 2019, Colloids and surfaces. B, Biointerfaces.

New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin

I. Berindan‐Neagoe, S. Korban, C. Braicu, 2020, Molecular and Cellular Biochemistry.

MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases

D. Matei, S. Pașca, B. Petrushev, 2020, Frontiers in Immunology.

The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View

O. Sorițău, S. Nicoară, I. Brie, 2021, International journal of molecular sciences.

Organ-On-A-Chip: A Survey of Technical Results and Problems

I. Berindan‐Neagoe, C. Braicu, E. Dulf, 2022, Frontiers in Bioengineering and Biotechnology.

Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.

I. Berindan‐Neagoe, A. Irimie, V. Pileczki, 2015, Journal of gastrointestinal and liver diseases : JGLD.

Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology

I. Berindan‐Neagoe, O. Bălăcescu, C. Braicu, 2016, BMC Genomics.

Circulating microRNA-194 and microRNA-1228 Could Predict Colon Cancer Proliferation via Phospho S6 Modulation.

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2020, Journal of gastrointestinal and liver diseases : JGLD.

Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient.

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2019, Histology and histopathology.

New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells.

I. Berindan‐Neagoe, A. Irimie, C. Braicu, 2020, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines—Possible Implications in New Therapeutic Strategies

I. Berindan‐Neagoe, A. Atanasov, A. Irimie, 2019, International journal of molecular sciences.

Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?

S. Aștilean, I. Berindan‐Neagoe, C. Braicu, 2017, Medical hypotheses.

Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study.

I. Berindan‐Neagoe, C. Tomuleasa, D. Ionescu, 2017, Journal of gastrointestinal and liver diseases : JGLD.

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia

S. Pașca, C. Tomuleasa, M. Zdrenghea, 2020, Medicina.

Human Chorionic Gonadotropin Improves the Proliferation and Regenerative Potential of Bone Marrow Adherent Stem Cells and the Immune Tolerance of Fetal Microchimeric Stem Cells In Vitro

C. Braicu, O. Sorițău, C. Moldovan, 2020, Stem Cell Reviews and Reports.

The new era of nanotechnology, an alternative to change cancer treatment

I. Berindan‐Neagoe, C. Braicu, C. Tomuleasa, 2017 .

Aberrant miRNAs expressed in HER-2 negative breast cancers patient

A. Paradiso, I. Berindan‐Neagoe, A. Irimie, 2018, Journal of Experimental & Clinical Cancer Research.

normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors

I. Berindan‐Neagoe, C. Braicu, P. Achimas-Cadariu, 2016 .

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2018, Critical reviews in clinical laboratory sciences.

Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer

I. Berindan‐Neagoe, R. Știufiuc, L. Tefas, 2022, Journal of liposome research.

miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes

A. Moldovan, C. Burz, A. Haranguș, 2024, Translational oncology.

Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.

G. Calin, A. Jurj, Beatrice Fontana, 2024, Trends in cancer.

MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in non-small cell lung cancer using a co-culture model

I. Berindan‐Neagoe, T. Ciuleanu, C. Braicu, 2023, Biomolecules & biomedicine.

17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer

M. Fabbri, G. Calin, A. Lucci, 2023, Proceedings of the National Academy of Sciences of the United States of America.

DNMT3A-NPM1 mutated acute myeloid leukaemia shows sensitivity to a PARP1 inhibitor combined with daunorubicin in an in vitro model

I. Berindan‐Neagoe, Lorand Magdo, V. Pileczki, 2018, bioRxiv.